Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Mar 11;3(3):CD012880.
doi: 10.1002/14651858.CD012880.pub2.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder

Affiliations
Meta-Analysis

Alcoholics Anonymous and other 12-step programs for alcohol use disorder

John F Kelly et al. Cochrane Database Syst Rev. .

Abstract

Background: Alcohol use disorder (AUD) confers a prodigious burden of disease, disability, premature mortality, and high economic costs from lost productivity, accidents, violence, incarceration, and increased healthcare utilization. For over 80 years, Alcoholics Anonymous (AA) has been a widespread AUD recovery organization, with millions of members and treatment free at the point of access, but it is only recently that rigorous research on its effectiveness has been conducted.

Objectives: To evaluate whether peer-led AA and professionally-delivered treatments that facilitate AA involvement (Twelve-Step Facilitation (TSF) interventions) achieve important outcomes, specifically: abstinence, reduced drinking intensity, reduced alcohol-related consequences, alcohol addiction severity, and healthcare cost offsets.

Search methods: We searched the Cochrane Drugs and Alcohol Group Specialized Register, Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, CINAHL and PsycINFO from inception to 2 August 2019. We searched for ongoing and unpublished studies via ClinicalTrials.gov and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) on 15 November 2018. All searches included non-English language literature. We handsearched references of topic-related systematic reviews and bibliographies of included studies.

Selection criteria: We included randomized controlled trials (RCTs), quasi-RCTs and non-randomized studies that compared AA or TSF (AA/TSF) with other interventions, such as motivational enhancement therapy (MET) or cognitive behavioral therapy (CBT), TSF treatment variants, or no treatment. We also included healthcare cost offset studies. Participants were non-coerced adults with AUD.

Data collection and analysis: We categorized studies by: study design (RCT/quasi-RCT; non-randomized; economic); degree of standardized manualization (all interventions manualized versus some/none); and comparison intervention type (i.e. whether AA/TSF was compared to an intervention with a different theoretical orientation or an AA/TSF intervention that varied in style or intensity). For analyses, we followed Cochrane methodology calculating the standard mean difference (SMD) for continuous variables (e.g. percent days abstinent (PDA)) or the relative risk (risk ratios (RRs)) for dichotomous variables. We conducted random-effects meta-analyses to pool effects wherever possible.

Main results: We included 27 studies containing 10,565 participants (21 RCTs/quasi-RCTs, 5 non-randomized, and 1 purely economic study). The average age of participants within studies ranged from 34.2 to 51.0 years. AA/TSF was compared with psychological clinical interventions, such as MET and CBT, and other 12-step program variants. We rated selection bias as being at high risk in 11 of the 27 included studies, unclear in three, and as low risk in 13. We rated risk of attrition bias as high risk in nine studies, unclear in 14, and low in four, due to moderate (> 20%) attrition rates in the study overall (8 studies), or in study treatment group (1 study). Risk of bias due to inadequate researcher blinding was high in one study, unclear in 22, and low in four. Risks of bias arising from the remaining domains were predominantly low or unclear. AA/TSF (manualized) compared to treatments with a different theoretical orientation (e.g. CBT) (randomized/quasi-randomized evidence) RCTs comparing manualized AA/TSF to other clinical interventions (e.g. CBT), showed AA/TSF improves rates of continuous abstinence at 12 months (risk ratio (RR) 1.21, 95% confidence interval (CI) 1.03 to 1.42; 2 studies, 1936 participants; high-certainty evidence). This effect remained consistent at both 24 and 36 months. For percentage days abstinent (PDA), AA/TSF appears to perform as well as other clinical interventions at 12 months (mean difference (MD) 3.03, 95% CI -4.36 to 10.43; 4 studies, 1999 participants; very low-certainty evidence), and better at 24 months (MD 12.91, 95% CI 7.55 to 18.29; 2 studies, 302 participants; low-certainty evidence) and 36 months (MD 6.64, 95% CI 1.54 to 11.75; 1 study, 806 participants; low-certainty evidence). For longest period of abstinence (LPA), AA/TSF may perform as well as comparison interventions at six months (MD 0.60, 95% CI -0.30 to 1.50; 2 studies, 136 participants; low-certainty evidence). For drinking intensity, AA/TSF may perform as well as other clinical interventions at 12 months, as measured by drinks per drinking day (DDD) (MD -0.17, 95% CI -1.11 to 0.77; 1 study, 1516 participants; moderate-certainty evidence) and percentage days heavy drinking (PDHD) (MD -5.51, 95% CI -14.15 to 3.13; 1 study, 91 participants; low-certainty evidence). For alcohol-related consequences, AA/TSF probably performs as well as other clinical interventions at 12 months (MD -2.88, 95% CI -6.81 to 1.04; 3 studies, 1762 participants; moderate-certainty evidence). For alcohol addiction severity, one study found evidence of a difference in favor of AA/TSF at 12 months (P < 0.05; low-certainty evidence). AA/TSF (non-manualized) compared to treatments with a different theoretical orientation (e.g. CBT) (randomized/quasi-randomized evidence) For the proportion of participants completely abstinent, non-manualized AA/TSF may perform as well as other clinical interventions at three to nine months follow-up (RR 1.71, 95% CI 0.70 to 4.18; 1 study, 93 participants; low-certainty evidence). Non-manualized AA/TSF may also perform slightly better than other clinical interventions for PDA (MD 3.00, 95% CI 0.31 to 5.69; 1 study, 93 participants; low-certainty evidence). For drinking intensity, AA/TSF may perform as well as other clinical interventions at nine months, as measured by DDD (MD -1.76, 95% CI -2.23 to -1.29; 1 study, 93 participants; very low-certainty evidence) and PDHD (MD 2.09, 95% CI -1.24 to 5.42; 1 study, 286 participants; low-certainty evidence). None of the RCTs comparing non-manualized AA/TSF to other clinical interventions assessed LPA, alcohol-related consequences, or alcohol addiction severity. Cost-effectiveness studies In three studies, AA/TSF had higher healthcare cost savings than outpatient treatment, CBT, and no AA/TSF treatment. The fourth study found that total medical care costs decreased for participants attending CBT, MET, and AA/TSF treatment, but that among participants with worse prognostic characteristics AA/TSF had higher potential cost savings than MET (moderate-certainty evidence).

Authors' conclusions: There is high quality evidence that manualized AA/TSF interventions are more effective than other established treatments, such as CBT, for increasing abstinence. Non-manualized AA/TSF may perform as well as these other established treatments. AA/TSF interventions, both manualized and non-manualized, may be at least as effective as other treatments for other alcohol-related outcomes. AA/TSF probably produces substantial healthcare cost savings among people with alcohol use disorder.

PubMed Disclaimer

Conflict of interest statement

JK: has received funding from the US National Institues of Health and the US Veterans Health Administration to conduct research into alcohol use disorders, comorbidities, treatment response, and mechanisms of behavior change in Alcoholics Anonymous (AA) and Self‐Management and Recovery Training (SMART).

KH: has received funding from the US National Institutes of Health and US Veterans Health Administration to evaluate a range of treatments and mutual‐help organizations focused on alcohol and other drugs.

MF: none known

Figures

1
1
PRISMA study flow diagram.
2
2
Manualized = the treatment covers standardized content in a linear or modular fashion to ensure that the same treatment is delivered across time and different sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the same treatment.
3
3
S = number of studies from Cochrane Review R = number of reports from Cochrane Review N = number of participants in the cell subcategory Manualized = the treatment covers standardized content in a linear or modular fashion to ensure that the same treatment is delivered across time and different sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the same treatment. aThe total Ns added across study types will not add to 10,565 because some of the participants that are in the other groupings (e.g. non‐randomized designs) are also in the economic category.
bWalitzer 2009 and its participants are included in both the 1A and 2A grouping in the review, but for the purposes of this table, the study and its participants (n = 169) are only counted once in the 1A group.
cOuimette 1997 and its participants are included in both the 3B and 4B grouping, but for the purposes of this table, the study and its participants (n = 3018) are only counted in the 3B group.
4
4
Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies.
5
5
Risk of bias summary: review authors' judgments about each risk of bias item for each included study. Note: 27 primary studies
1.1
1.1. Analysis
Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 1: Proportion completely abstinent
1.2
1.2. Analysis
Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 2: Percentage days abstinent (PDA)
1.3
1.3. Analysis
Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 3: Longest period of abstinence (LPA, months)
1.4
1.4. Analysis
Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 4: Drinks per drinking day (DDD)
1.5
1.5. Analysis
Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 5: Percentage days heavy drinking (PDHD)
1.6
1.6. Analysis
Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 6: Alcohol‐related consequences (DrInC)
1.7
1.7. Analysis
Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 7: Alcohol‐related consequences (SIP)
1.8
1.8. Analysis
Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 8: Alcohol‐related consequences (SIP‐2R)
1.9
1.9. Analysis
Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 9: Addiction Severity Index (ASI)
2.1
2.1. Analysis
Comparison 2: 1B Grouping: RCT/quasi‐RCT, 1 + treatments non‐manualized, compared to different theoretical orientation, Outcome 1: Proportion completely abstinent
2.2
2.2. Analysis
Comparison 2: 1B Grouping: RCT/quasi‐RCT, 1 + treatments non‐manualized, compared to different theoretical orientation, Outcome 2: Percentage days abstinent (PDA)
2.4
2.4. Analysis
Comparison 2: 1B Grouping: RCT/quasi‐RCT, 1 + treatments non‐manualized, compared to different theoretical orientation, Outcome 4: Drinks per drinking day (DDD)
2.5
2.5. Analysis
Comparison 2: 1B Grouping: RCT/quasi‐RCT, 1 + treatments non‐manualized, compared to different theoretical orientation, Outcome 5: Percentage days heavy drinking (PDHD)
3.1
3.1. Analysis
Comparison 3: 2A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to TSF variant, Outcome 1: Proportion of participants completely abstinent
3.2
3.2. Analysis
Comparison 3: 2A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to TSF variant, Outcome 2: Percentage days abstinent (PDA)
3.3
3.3. Analysis
Comparison 3: 2A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to TSF variant, Outcome 3: Days of use (PDA)
3.4
3.4. Analysis
Comparison 3: 2A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to TSF variant, Outcome 4: Drinks per drinking day (DDD)
3.5
3.5. Analysis
Comparison 3: 2A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to TSF variant, Outcome 5: Addiction Severity Index (ASI)
3.6
3.6. Analysis
Comparison 3: 2A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to TSF variant, Outcome 6: European Addiction Severity Index (EuropASI)
4.1
4.1. Analysis
Comparison 4: 2B Grouping: RCT/quasi‐RCT, 1 + treatments non‐manualized, compared to TSF variant, Outcome 1: Proportion of participants completely abstinent
5.1
5.1. Analysis
Comparison 5: 3B: Non‐randomized, 1+ treatments non‐manualized, compared to different theoretical orientation, Outcome 1: Proportion of participants completely abstinent
5.2
5.2. Analysis
Comparison 5: 3B: Non‐randomized, 1+ treatments non‐manualized, compared to different theoretical orientation, Outcome 2: Drinks per drinking day (DDD)
5.3
5.3. Analysis
Comparison 5: 3B: Non‐randomized, 1+ treatments non‐manualized, compared to different theoretical orientation, Outcome 3: Alcohol‐related consequences (SIP)
5.4
5.4. Analysis
Comparison 5: 3B: Non‐randomized, 1+ treatments non‐manualized, compared to different theoretical orientation, Outcome 4: Alcohol‐related consequences
5.5
5.5. Analysis
Comparison 5: 3B: Non‐randomized, 1+ treatments non‐manualized, compared to different theoretical orientation, Outcome 5: Alcohol addiction severity (Alcohol Dependence Scale)
6.1
6.1. Analysis
Comparison 6: 4B: Non‐randomized, 1+ treatments non‐manualized, compared to TSF variant, Outcome 1: Proportion completely abstinent
6.2
6.2. Analysis
Comparison 6: 4B: Non‐randomized, 1+ treatments non‐manualized, compared to TSF variant, Outcome 2: Percentage days abstinent (PDA)
6.4
6.4. Analysis
Comparison 6: 4B: Non‐randomized, 1+ treatments non‐manualized, compared to TSF variant, Outcome 4: Addition Severity Index‐Lite (ASI‐L)

Comment in

References

References to studies included in this review

Blondell 2001 {published data only}
    1. Blondell RD, Looney SW, Northington AP, Lasch ME, Rhodes SB, McDaniels RL. Using recovering alcoholics to help hospitalized patients with alcohol problems. Journal of Family Practice 2001;50(5):1-15. - PubMed
Blondell 2011 {published data only}
    1. Blondell RD, Frydrych LM, Jaanimaqi U, Ashrafioun L, Homish GG, Foschio EM, et al. A randomized trial of two behavioral interventions to improve outcomes following inpatient detoxification for alcohol dependence. Journal of Addictive Diseases 2011;30(2):136-48. [DOI: 10.1080/10550887.2011.554777] - DOI - PMC - PubMed
Bogenschutz 2014 {published data only}
    1. Bogenschutz MP, Rice SL, Tonigan JS, Vogel HS, Nowinski J, Hume D, et al. 12-step facilitation for the dually diagnosed: a randomized clinical trial. Journal of Substance Abuse Treatment 2014;46(4):403-11. [DOI: 10.1016/j.jsat.2013.12.009] - DOI - PMC - PubMed
Bowen 2014 {published data only}
    1. Bowen S, Witkiewitz K, Clifasefi SL, Grow J, Chawla N, Hsu SH, et al. Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial. JAMA Psychiatry 2014;71(5):547-56. [DOI: 10.1001/jamapsychiatry.2013.4546] - DOI - PMC - PubMed
Brooks 2003 {published data only}
    1. Brooks AJ, Penn PE. Comparing treatments for dual diagnosis: twelve-step and self-management and recovery training. American Journal of Drug and Alcohol Abuse 2003;29(2):359-83. [DOI: 10.1081/ADA-120020519] - DOI - PubMed
Brown 2002 {published data only}
    1. Brown TG, Seraganian P, Tremlay J, Annis H. Process and outcome changes with relapse prevention versus 12-step aftercare programs for substance abusers. Addiction 2002;976(6):677-89. - PubMed
Davis 2002 {published data only}
    1. Davis WT, Campbell L, Tax J, Lieber CS. A trial of 'standard' outpatient alcoholism treatment vs. a minimal treatment control. Journal of Substance Abuse Treatment 2002;23(1):9-19. [DOI: 10.1016/S0740-5472(02)00227-1] - DOI - PubMed
Grant 2018 {published data only}
    1. Grant KM, Young LB, Tyler KA, Simpson JL, Pulido RD, Timko C. Intensive referral to mutual-help groups: a field trial of adaptations for rural veterans. Patient Education and Counseling 2018;101(1):79-84. [DOI: 10.1016/j.pec.2017.07.012] - DOI - PMC - PubMed
Herman 2000 {published data only}
    1. Herman SE, Frank KA, Mowbray CT, Ribisl KM, Davidson WS 2nd, Boots Miller B, et al. Longitudinal effects of integrated treatment on alcohol use for persons with serious mental illness and substance use disorders. Journal of Behavioral Health Services & Research 2000;27(3):286-302. [DOI: ] - PubMed
Humphreys 1996 {published data only}
    1. Humphreys K, Moos RH. Reduced substance-abuse-related health care costs among voluntary participants in Alcoholics Anonymous. Psychiatric Services 1996;47(7):709-13. [DOI: 10.1176/ps.47.7.709] - DOI - PubMed
Kahler 2004 {published data only}
    1. Kahler CW, Read JP, Ramsey SE, Stuart GL, McCrady BS, Brown RA. Motivational enhancement for 12-step involvement among patients undergoing alcohol detoxification. Journal of Consulting and Clinical Psychology 2004;72(4):736-41. [DOI: 10.1037/0022-006X.72.4.736] - DOI - PubMed
Kaskutas 2009b {published data only}
    1. Kaskutas LA, Subbaraman MS, Witbrodt J, Zemore SE. Effectiveness of making alcoholics anonymous easier: a group format 12-step facilitation approach. Journal of Substance Abuse Treatment 2009;37(3):228-39. [DOI: 10.1016/j.jsat.2009.01.004] - DOI - PMC - PubMed
Kelly 2017b {published data only}
    1. Kelly JF, Kaminer Y, Kahler CW, Hoeppner B, Yeterian J, Cristello JV, et al. A pilot randomized clinical trial testing integrated 12‐step facilitation (iTSF) treatment for adolescent substance use disorder. Addiction 2017;112(12):2155-66. [DOI: 10.1111/add.13920] - DOI - PMC - PubMed
Litt 2007 {published data only}
    1. Litt MD, Kadden RM, Kabela-Cormier E, Petry N. Changing network support for drinking: initial findings from the network support project. Journal of Consulting and Clinical Psychology 2007;75(4):542-55. [DOI: 10.1037/0022-006X.75.4.542] - DOI - PubMed
    1. Litt MD, Kadden RM, Kabela-Cormier E, Petry NM. Changing network support for drinking: Network Support Project 2-year follow-up. Journal of Consulting and Clinical Psychology 2009;77(2):229-42. [DOI: 10.1037/a0015252] - DOI - PMC - PubMed
Litt 2016 {published data only}
    1. Litt MD, Kadden RM, Tennen H, Kabela-Cormier E. Network Support II: randomized controlled trial of Network Support treatment and cognitive behavioral therapy for alcohol use disorder. Drug and Alcohol Dependence 2016;165:203-12. [DOI: 10.1016/j.drugalcdep.2016.06.010] - DOI - PMC - PubMed
Lydecker 2010 {published data only}
    1. Lydecker KP, Tate SR, Cummins KM, McQuaid J, Granholm E, Brown SA. Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors 2010;24(3):453-65. [DOI: 10.1037/a0019943] - DOI - PMC - PubMed
Manning 2012 {published data only}
    1. Manning V, Best D, Faulkner N, Titherington E, Morinan A, Keaney F, et al. Does active referral by a doctor or 12-step peer improve 12-step meeting attendance? Results from a pilot randomised control trial. Drug and Alcohol Dependence 2012;126(1-2):131-7. [DOI: 10.1016/j.drugalcdep.2012.05.004] - DOI - PubMed
MATCH 1997 {published data only}
    1. Holder HD, Cisler RA, Longabaugh R, Stout RL, Treno AJ, Zweben A. Alcoholism treatment and medical care costs from Project MATCH. Addiction 2000;95(7):999-1013. [DOI: 10.1046/j.1360-0443.2000.9579993.x] - DOI - PubMed
    1. Longabaugh R, Wirtz PW, Zweben A, Stout RL. Network support for drinking, Alcoholics Anonymous and long-term matching effects. Addiction 1998;93(9):1313-33. [DOI: 10.1046/j.1360-0443.1998.93913133.x] - DOI - PubMed
    1. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol and Drugs 1997;58(1):7-29. - PubMed
    1. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcoholism: Clinical and Experimental Research 1998;22(6):1300-11. [DOI: 10.1111/j.1530-0277.1998.tb03912.x] - DOI - PubMed
    1. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. 1998 Journal of Studies on Alcohol and Drugs;59(6):631-9. [DOI: 10.15288/jsa.1998.59.631] - DOI - PubMed
McCrady 1996 {published data only}
    1. McCrady BS, Epstein EE, Hirsch LS. Issues in the implementation of a randomized clinical trial that includes Alcoholics Anonymous: studying AA-related behaviors during treatment. Journal of Studies on Alcohol and Drugs 1996;57(6):604-12. [DOI: 10.15288/jsa.1996.57.604] - DOI - PubMed
    1. McCrady BS, Epstein EE, Hirsch LS. Maintaining change after conjoint behavioral alcohol treatment for men: Outcomes at 6 months. Addiction 1999;94(9):1381-96. [DOI: 10.1046/j.1360-0443.1999.949138110.x] - DOI - PubMed
    1. McCrady BS, Epstein EE, Kahler CW. Alcoholics Anonymous and relapse prevention as maintenance strategies after conjoint behavioral alcohol treatment for men: 18-Month outcomes. Journal of Consulting and Clinical Psychology 2004;72(5):870-8. [DOI: 10.1037/0022-006X.72.5.870] - DOI - PubMed
Mundt 2012 {published data only}
    1. Mundt MP, Parthasarathy S, Chi FW, Sterling S, Campbell CI. 12-step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment. Drug and Alcohol Dependence 2012;126(1-2):124-30. [DOI: 10.1016/j.drugalcdep.2012.05.002] - DOI - PMC - PubMed
Ouimette 1997 {published data only}
    1. Humphreys K, Moos R. Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research 2001;25(5):711-16. - PubMed
    1. Humphreys K, Moos RH. Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research 2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x] - DOI - PubMed
    1. Ouimette PC, Finney JW, Moos RH. Twelve-step and cognitive-behavioral treatment for substance abuse: A comparison of treatment effectiveness. Journal of Consulting and Clinical Psychology 1997;65(2):230-40. [DOI: 10.1037//0022-006X.65.2.230] - DOI - PubMed
Timko 2006 {published data only}
    1. Timko C, DeBenedetti A. A randomized controlled trial of intensive referral to 12-step self-help groups: One-year outcomes. Drug and Alcohol Dependence 2007;90(2-3):270-9. - PubMed
    1. Timko C, Debenedetti A, Billow R. Intensive referral to 12-step self-help groups and 6-month substance use disorder outcomes. Addiction 2006;101(5):678-88. [DOI: 10.1111/j.1360-0443.2006.01391.x] - DOI - PubMed
Timko 2011 {published data only}
    1. Timko C, Sutkowi A, Cronkite RC, Makin-Byrd K, Moos RH. Intensive referral to 12-step dual-focused mutual-help groups. Drug and Alcohol Dependence 2011;118(2-3):194-201. [DOI: 10.1016/j.drugalcdep.2011.03.019] - DOI - PubMed
Vederhus 2014 {published data only}
    1. Vederhus JK, Timko C, Kristensen O, Hjemdahl B, Clausen T. Motivational intervention to enhance post‐detoxification 12‐step group affiliation: a randomized controlled trial. Addiction 2014;109(5):766-73. [DOI: 10.1111/add.12471] - DOI - PMC - PubMed
Walitzer 2009 {published data only}
    1. Walitzer KS, Dermen KH, Barrick C. Facilitating involvement in alcoholics anonymous during out-patient treatment: A randomized clinical trial. Addiction 2009;104(3):391-401. [DOI: 10.1111/j.1360-0443.2008.02467.x] - DOI - PMC - PubMed
Walitzer 2015 {published data only}
    1. Walitzer KS, Deffenbacher JL, Shyhalla K. Alcohol-adapted anger management treatment: a randomized controlled trial of an innovative therapy for alcohol dependence. Journal of Substance Abuse Treatment 2015;59:83-93. [DOI: 10.1016/j.jsat.2015.08.003] - DOI - PMC - PubMed
Zemore 2018 {published data only}
    1. Zemore SE, Lui C, Mericle A, Hemberg J, Kaskutas LA. A longitudinal study of the comparative efficacy of Women for Sobriety, LifeRing, SMART Recovery, and 12-step groups for those with AUD. Journal of Substance Abuse Treatment 2018;88:18-26. [DOI: 10.1016/j.jsat.2018.02.004] - DOI - PMC - PubMed

References to studies excluded from this review

Banerjee 2007 {published data only}
    1. Banerjee K, Howard M, Mansheim K, Beattie M. Comparison of Health Realization and 12-step treatment in women's residential substance abuse treatment programs. American Journal of Drug and Alcohol Abuse 2007;33(2):207-15. [DOI: 10.1080/00952990601174758] - DOI - PubMed
Hailemariam 2018 {published data only}
    1. Hailemariam M, Stein M, Anderson B, Schonbrun YC, Moore K, Kurth M, et al. Correlates of alcoholics anonymous affiliation among justice-involved women. BMC Women's Health 2018;18(1):125. [DOI: 10.1186/s12905-018-0614-0] - DOI - PMC - PubMed
Lash 2011 {published data only}
    1. Lash SJ, Timko C, Curran GM, McKay JR, Burden JL. Implementation of evidence-based substance use disorder continuing care interventions. Psychology of Addictive Behaviors 2011;25(2):238-51. [DOI: 10.1037/a0022608] - DOI - PMC - PubMed
Lash 2013 {published data only}
    1. Lash SJ, Burden JL, Parker JD, Stephens RS, Budney AJ, Horner RD, et al. Contracting, prompting and reinforcing substance use disorder continuing care. Journal of Substance Abuse Treatment 2013;44(4):449-56. [DOI: 10.1016/j.jsat.2012.09.008] - DOI - PubMed
Laudet 2007 {published data only}
    1. Laudet A, Stanick V, Sands B. An exploration of the effect of on-site 12-step meetings on post-treatment outcomes among polysubstance-dependent outpatient clients. Evaluation Review 2007;31(6):613-43. [DOI: 10.1177/0193841X07306745] - DOI - PMC - PubMed
Moos 1999 {published data only}
    1. Moos RH, Moos BS, Andrassy JM. Outcomes of four treatment approaches in community residential programs for patients with substance use disorders. Psychiatry Services 1999;50(12):1577-83. [DOI: 10.1176/ps.50.12.1577] - DOI - PubMed
Morgan‐Lopez 2013 {published data only}
    1. Morgan-Lopez AA, Saavedra LM, Hien DA, Campbell AN, Wu E, Ruglass L. Synergy between seeking safety and twelve-step affiliation on substance use outcomes for women. Journal of Substance Abuse Treatment 2013;45(2):179-89. [DOI: 10.1016/j.jsat.2013.01.015] - DOI - PMC - PubMed
Mueller 2007 {published data only}
    1. Mueller SE, Petitjean S, Boening J, Wiezbeck GA. The impact of self-help group attendance on relapse rates after alcohol detoxification in a controlled study. Alcohol and Alcoholism 2007;42(2):108-12. [DOI: 10.1093/alcalc/agl122] - DOI - PubMed
Schilling 2002 {published data only}
    1. Schilling RF, El-Bassel N, Finch JB, Roman RJ, Hanson M. Motivational interviewing to encourage self-help participation following alcohol detoxification. Research on Social Work Practice 2002;12(6):711-30. [DOI: 10.1177/104973102237469] - DOI
Ståhlbrandt 2007 {published data only}
    1. Ståhlbrandt H, Johnsson KO, Berglund M. Two-year outcome of alcohol interventions in Swedish university halls of residence: a cluster randomized trial of a brief skills training program, twelve-step-influenced intervention, and controls. Alcoholism: Clinical and Experimental Research 2007;31(3):458-66. [DOI: 10.1111/j.1530-0277.2006.00327.x] - DOI - PubMed
Tonigan 2010 {published data only}
    1. Tonigan JS, Book SW, Pagano ME, Randall PK, Smith JP, Randall CL. 12-step therapy and women with and without social phobia: a study of the effectiveness of 12-step therapy to facilitate alcoholics anonymous engagement. Alcoholism Treatment Quarterly 2010;28(2):151-62. [DOI: 10.1080/07347321003648596] - DOI - PMC - PubMed
Villanueva 2007 {published data only}
    1. Villanueva M, Tonigan JS, Miller WR. Response of Native American clients to three treatment methods for alcohol dependence. Journal of Ethnicity in Substance Abuse 2007;6(2):41-8. [DOI: doi: 10.1300/J233v06n02_04] - PubMed
Walsh 1991 {published data only}
    1. Walsh DC, Hingson RW, Merrigan DM, Levenson SM, Cupples LA, Heeren T, et al. A randomized trial of treatment options for alcohol-abusing workers. New England Journal of Medicine 1991;325(11):775-82. [DOI: 10.1056/NEJM199109123251105] - DOI - PubMed

Additional references

Alcoholics Anonymous 2001
    1. Alcoholics Anonymous. Alcoholics Anonymous: The Story of How Thousands of Men and Women have Recovered from Alcoholism. 4th edition. New York (NY): Alcoholics Anonymous World Services, 2001.
Alcoholics Anonymous 2018
    1. Alcoholics Anonymous. One Big Tent. New York (NY): AA Grapevine, Inc, 2018.
APA 1994
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington (DC): American Psychiatric Association, 1994.
APA 2013
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th edition. Washington (DC): American Psychiatric Association, 2013.
Bøg 2017
    1. Bøg M, Filges T, Brännström L, Jørgensen AM, Fredriksson MK. 12-step programs for reducing illicit drug use: a systematic review. Cambell Systematic Reviews 2017;2. [DOI: 10.4073/csr.2017.2] - DOI
Caetano 1998
    1. Caetano R, Clark CL, Greenfield TK. Prevalence, trends, and incidence of alcohol withdrawal symptoms: analysis of general population and clinical samples. Alcohol Health and Research World 1998;22(1):73-9. - PMC - PubMed
Drummond 2005
    1. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. 3rd edition. Oxford (UK): Oxford University Press, 2005.
Ducharme 2006
    1. Ducharme LJ, Knudsen HK, Roman PM. Trends in the adoption of medication for alcohol dependence. Journal of Clinical Psychopharmacology 2006;26(6):S13-9. [DOI: 10.1097/01.jcp.0000246209.18777.14] - DOI - PubMed
Dunn 1997
    1. Dunn CW, Donovan DM, Gentilello LM. Practical guidelines for performing alcohol interventions in trauma centers. Journal of Trauma: Injury, Infection, and Critical Care 1997;42(2):299-304. - PubMed
Evers 2005
    1. Evers S, Goossens M, Vet H, Tulder M, Ament A. Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria. International Journal of Technology Assessment in Health Care 2005;21(2):240-5. - PubMed
GRADEpro GDT 2015 [Computer program]
    1. GRADE Working Group, McMaster University GRADEpro GDT. Hamilton (ON): GRADE Working Group, McMaster University, 2015. Available at gradepro.org.
Hedden 2015
    1. Hedden SL, Kennet J, Lipari R, Medley G, Tice P, Copello EA, et al, SAMHSA. Behavioral health trends in the United States: results from the 2014 National Survey on Drug Use and Health. www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR1-2014.pdf (accessed prior to 25 November 2019).
Herman 1997
    1. Herman SE, BootsMiller B, Jordan L, Mowbray CT, Brown WG, Deiz N, et al. Immediate outcomes of substance use treatment within a state psychiatric hospital. Journal of Mental Health Administration 1197;24(2):126-38. - PubMed
Higgins 2011a
    1. Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Higgins 2011b
    1. Higgins JP, Deeks JJ, Altman DG, editor(s). Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Hoffman 2009
    1. Hoffman F. Cultural adaptations of Alcoholics Anonymous to serve Hispanic populations. International Journal of the Addictions 2009;29(4):445-60. [DOI: ] - PubMed
Holder 2000
    1. Holder HD, Cisler RA, Longabaugh R, Stout RL, Treno AJ, Zweben A. Alcoholism treatment and medical care costs from Project MATCH. Addiction 2000;95(7):999-1013. [10.1046/j.1360-0443.2000.9579993.x] - PubMed
Humphreys 1994
    1. Humphreys K, Mavis BE, Stöffelmayr BE. Are twelve step programs appropriate for disenfranchised groups? Evidence from a study of posttreatment mutual help group involvement. Prevention in Human Services 1994;11(1):165-80.
Humphreys 1999
    1. Humphreys K. Professional interventions that facilitate 12-step self-help group involvement. Alcohol Health and Research World 1999;23(2):93-8. - PMC - PubMed
Humphreys 2001
    1. Humphreys K, Moos R. Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research 2001;25(5):711-6. - PubMed
Humphreys 2004
    1. Humphreys K. Circles of Recovery: Self-Help Organizations for Addictions. Cambridge, UK: Cambridge University Press, 2004.
Humphreys 2007
    1. Humphreys K, Moos RH. Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research 2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x] - DOI - PubMed
Humphreys 2014
    1. Humphreys K, Blodgett JC, Wagner TH. Estimating the efficacy of Alcoholics Anonymous without self-selection bias: an instrumental variables re-analysis of randomized clinical trials. Alcoholism, Clinical and Experimental Research 2014;38(11):2688-94. [DOI: 10.1111/acer.12557] - DOI - PMC - PubMed
Jilek‐Aall 1981
    1. Jilek-Aall L. Acculturation, alcoholism, and Indian-style Alcoholics Anonymous. Journal of Studies on Alcohol, Supplement 1981;S9:143-58. [DOI: ] - PubMed
Kaskutas 2009a
    1. Kaskutas LA. Alcoholics Anonymous effectiveness: faith meets science. Journal of Addictive Diseases 2009;28(2):145-57. [DOI: 10.1080/10550880902772464] - DOI - PMC - PubMed
Kelly 2003a
    1. Kelly JF, McKellar JD, Moos RH. Major depression in patients with substance use disorders: Relationships to 12-step self-help involvement and substance use outcomes. Addiction 2003;98(4):499-508. - PubMed
Kelly 2003b
    1. Kelly JF. Self-help for substance-use disorders: history, effectiveness, knowledge gaps, and research opportunities. Clinical Psychology Review 2003;23(5):639-663. [DOI: 10.1016/S0272-7358(03)00053-9] - DOI - PubMed
Kelly 2009a
    1. Kelly JF, McCrady BS. Twelve-step facilitation in non-specialty settings. In: Research on alcoholism: Alcoholics Anonymous and spiritual aspects of recovery. New York, NY: Springer, 2009:797-836.
Kelly 2009b
    1. Kelly JF, Magill M, Stout RL. How do people recover from alcohol dependence? A systematic review of the research on mechanisms of behavior change in Alcoholics Anonymous. Addiction Research & Theory 2009;17(3):236-59. [http://dx.doi.org/10.1080/16066350902770458]
Kelly 2012
    1. Kelly JF, White WL. Broadening the base of addiction mutual-help organizations. Journal of Groups in Addiction and Recover 2012;7(2-4):82-101. [DOI: ]
Kelly 2013a
    1. Kelly JK, Yeterian J. Mutual-help groups for alcohol and other substance use disorders. In: McCrady BS, Epstein EE, editors(s). Addictions: A Comprehensive Guidebook. 2nd edition. New York, NY: Oxford University Press, 2013:500-25.
Kelly 2013b
    1. Kelly JF, Greene MC. The twelve promises of Alcoholics Anonymous: psychometric validation and mediational testing as a 12-step specific mechanism of behavior change. Drug and Alcohol Dependence 2013;133(2):633-40. [DOI: 10.1016/j.drugalcdep.2013.08.006] - DOI - PMC - PubMed
Kelly 2013c
    1. Kelly JF, Humphreys K, Yeterian J. Mutual-Help Groups. In: Herie M, Skinner WJW, editors(s). Fundamentals of Addiction: A Practical Guide for Counsellors. Toronto (ON): Centre on Addiction and Mental Health, 2013:321-48.
Kelly 2014
    1. Kelly JF, Greene MC, Bergman BG. Do drug dependent patients attending Alcoholics Anonymous rather than Narcotics Anonymous do as well? A prospective, lagged, matching analysis. Alcohol and Alcoholism 2014;49(6):645-53. [DOI: ] - PMC - PubMed
Kelly 2017a
    1. Kelly J. Is Alcoholics Anonymous religious, spiritual, neither? Findings from 25 years of mechanisms of behavior change research. Addiction 2017;112(6):929-36. [DOI: 10.1111/add.13590] - DOI - PMC - PubMed
Kelly 2018
    1. Kelly JF, Greene MC, Bergman BG. Beyond abstinence: changes in indices of quality of life with time in recovery in a nationally representative sample of U.S. adults. Alcoholism: Clinical and Experimental Research 2018;42(4):770-80. [DOI: 10.1111/acer.13604] - DOI - PMC - PubMed
Knudsen 2016
    1. Knudsen HK, Roman PM. Service delivery and pharmacotherapy for alcohol use disorder in the era of health reform: data from a national sample of treatment organizations. Substance Abuse 2016;37(1):230-7. [DOI: 10.1080/08897077.2015.1028699] - DOI - PMC - PubMed
Liberati 2009
    1. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Medicine 2009;6(7):e1000100. - PMC - PubMed
Longabaugh 1998
    1. Longabaugh R, Wirtz PW, Zweben A, Stout RL. Network support for drinking, Alcoholics Anonymous and long-term matching effects. Addiction 1998;93(9):1313-33. [DOI: 10.1046/j.1360-0443.1998.93913133.x]] - PubMed
Mann 2006a
    1. Mann RE, Zalcman RF, Smart RG, Rush BR, Suurvali H. Alcohol consumption, alcoholics anonymous membership, and homicide mortality rates in Ontario 1968 to 1991. Alcoholism: Clinical and Experimental Research 2006;30(10):1743-51. [DOI: 10.1111/j.1530-0277.2006.00216.x] - DOI - PubMed
Mann 2006b
    1. Mann RE, Zalcman RF, Smart RG, Rush BR, Suurvali H. Alcohol consumption, alcoholics anonymous membership, and suicide mortality rates, Ontario, 1968-1991. Journal of Studies on Alcohol and Drugs 2006;67(3):445-53. - PubMed
Marlatt 1985
    1. Marlatt GA, Gordon JR. Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. New York (NY): Guilford Press, 1985.
MATCH 2001
    1. Project MATCH . Project MATCH hypotheses: results and causal chain analyses. In: Longabaugh R, Wirtz PW, Mattson ME, Myers JK, editors(s). National Institute on Alcohol Abuse and Alcoholism Project MATCH Monograph Series Volume 8. Vol. 8. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, 2001.
McCrady 1993
    1. McCrady BS, Miller WR. Research on Alcoholics Anonymous: Opportunities and Alternatives. New Brunswick (NJ): Rutgers Center of Alcohol Studies, 1993.
McLellan 1980
    1. McLellan AT, Luborsky L, O’Brien CP, Woody GE. An improved diagnostic instrument for substance abuse patients: the addiction severity index. Journal of Nervous & Mental Diseases 1980;168(1):26-33. - PubMed
Miller 1995
    1. Miller WR, Tonigan JS, Longabaugh R. The Drinker Inventory of Consequences (DrInC): An Instrument for Assessing Adverse Consequences of Alcohol Abuse: Test Manual. Vol. 4, Project MATCH Monograph. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism, 1995.
Moher 2009
    1. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLos Medicine 2009;6(7):e1000097. [DOI: 10.1371/journal.pmed1000097] - DOI - PMC - PubMed
OSG 2018
    1. US Department of Health and Human Services (HHS), Office of the Surgeon General. Facing addiction in America: the surgeon general’s spotlight on opioids. addiction.surgeongeneral.gov/sites/default/files/Spotlight-on-Opioids_09... September 2018.
Room 2006
    1. Room R, Makela P, Schmidt L, Rehm J. Alcohol, Health Disparities and Development. www.robinroom.net/Alchealth.pdf (accessed 9 November 2017).
Rosenbaum 2015
    1. Rosenbaum BP, Kshettry VR, Kelly ML, Weil RJ. Diagnoses associated with the greatest years of potential life lost for in-hospital deaths in the United States, 1988-2010. Public Health 2015;129(2):173-81. [DOI: 10.1016/j.puhe.2014.11.011] - DOI - PubMed
Sacks 2015
    1. Sacks JJ, Gonzales KR, Bouchery EE, Tomedi LE, Brewer RD. 2010 National and State Costs of Excessive Alcohol Consumption. American Journal of Preventive Medicine 2015;49(5):e73-9. [DOI: ] - PubMed
Schunemann 2013
    1. Schunemann H, Brozek J, Guyatt G, Oxman A, editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.
Shemilt 2011a
    1. Shemilt I, Mugford M, Byford S, Drummond M, Eisenstein E, Knapp M, et al. Chapter 15: Incorporating economics evidence. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Shemilt 2011b
    1. Shemilt I, Mugford M, Byford S, Drummond M, Eisenstein E, Knapp M, et al. Chapter 15: Incorporating economics evidence. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Stahre 2014
    1. Stahre M, Roeber J, Kanny D, Brewer R, Zhang X. Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States. Preventing Chronic Disease 2014;11:E109. [DOI: ] - PMC - PubMed
Sterne 2011
    1. Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention.. Available from handbook.cochrane.org.
Sterne 2016
    1. Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomized studies of interventions. BMJ 2016;355:i4919. [DOI: 10.1136/bmj.i4919.] - DOI - PMC - PubMed
Tonigan 2018
    1. Tonigan JS, Pearson MR, Magill M, Hagler KJ. AA attendance and abstinence for dually diagnosed patients: a meta-analytic review. Addiction 2018;113(11):1970-81. [DOI: 10.1111/add.14268] - DOI - PubMed
White 2012
    1. White WL, Kelly JF, Roth JD. New addiction recovery support institutions: Mobilizing support beyond professional addiction treatment and recovery mutual aid. Journal of Groups in Addiction & Recovery 2012;7:297-317. [DOI: ]
WHO 2010
    1. World Health Organization. International Statistical Classification of Diseases and Related Health Problems: ICD-10. 10th edition. Vol. 2. Geneva: World Health Organization, 2010.
WHO 2014
    1. World Health Organization. Global Status Report on Alcohol and Health. Geneva, Switzerland: World Health Organization, 2014.
Yalom 2008
    1. Yalom ID, Leszcz M. The Theory and Practice of Group Psychotherapy. 5th edition. New York (NY): Basic Books, 2008.
Zemore 2004
    1. Zemore SE, Kaskutas LA, Ammon LN. In 12-step groups, helping helps the helper. Addiction 2004;99(8):1015-23. [DOI: 10.1111/j.1360-0443.2004.00782.x] - DOI - PubMed
Zemore 2017
    1. Zemore SE, Kaskutas LA, Mericle A, Hemberg J. Comparison of 12-step groups to mutual help alternatives for AUD in a large, national study: differences in membership characteristics and group participation, cohesion, and satisfaction. Journal of Substance Abuse Treatment 2017;73:16-26. [DOI: 10.1016/j.jsat.2016.10.004] - DOI - PMC - PubMed

References to other published versions of this review

Ferri 2006a
    1. Ferri M, Amato L, Davoli M. 12-step programmes and Alcoholics Anonymous for alcohol dependence. Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No: CD005032. [DOI: 10.1002/14651858.CD005032.pub2] - DOI - PMC - PubMed
Ferri 2006b
    1. Ferri M, Amato L, Davoli M. Alcoholics Anonymous and other 12-step programmes for alcohol dependence. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No: CD005032. [DOI: 10.1002/14651858.CD005032.pub2] - DOI - PMC - PubMed
Kelly 2017c
    1. Kelly JF, Humphreys K, Ferri M. Alcoholics Anonymous and other 12-step programs for alcohol use disorder. Cochrane Database of Systematic Reviews 2017, Issue 11. Art. No: CD012880. [DOI: 10.1002/14651858.CD012880] - DOI - PMC - PubMed

Publication types